"We would encourage you to visit www.coronavirus.gov for the latest information and guidance related to COVID-19"
Early Bird registration closes on: September 22, 2023
Get your pass now until price go up & save 40%
Walter Straus, MD, MPH, FACP
Vice-President, Clinical Safety, Moderna
Ofer Levy, MD, PhD
Staff Physician & Principal Investigator, Director, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital Professor, Harvard Medical School
David B. Weiner, Ph.D.
Executive Vice President, The Wistar Institute, Director, Vaccine & Immunotherapy Center
Gary Kobinger, PhD, OM, MSC
Director, Galveston National Laboratory
Marco Pravetoni, Ph.D.
Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Director, Center for Medication Development for Substance Use Disorders and Overdose
Barbara A Jones, Ph.D.
IBM Quantum, IBM Research Almaden
Alexander Bukreyev, Ph.D.
Professor, Co-Principal Investigator Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus, Departments of Pathology and Microbiology & Immunology, Galveston National Laboratory, University of Texas Medical Branch
Stephen L. Hoffman, M.D.
Chief Executive and Scientific Officer, Sanaria Inc.
Rama Rao Amara, Ph.D.
Charles Howard Candler Professor, Department of Microbiology and Immunology, Associate Director, Vaccine Development, Emory Vaccine Center, Co-Director, Developmental Core, Emory CFAR, Emory National Primate Research Center, Emory University
Magdalena Tary-Lehmann, M.D., Ph.D.
Chief Scientific Officer, Cellular Technology Limited, Adjunct Associate Professor of Pathology, Case Western Reserve University
John Shon, MD, MS
Chief Technology Officer, Serimmune
Shahin Gharakhanian, MD, DPH
Pharmaceutical Medicine, Infectious Diseases, Member, IDSA: Infectious Diseases Society of America. Shahin Gharakhanian MD Consulting LLC
Biao He, Ph.D.
President & CEO, CyanVac LLC
Christopher Rudd, PhD, DSc, FRSC
Professeur, Faculte de Medicine, Dept de microbiologie, infectiologie et immunologie, Director-Cell Signaling and Immunotherapy Section, Centre de Recherche Hopital Maisonneuve-Rosemont
Sriram Sathy, Ph.D.
Chief Scientific Officer, Codiak
Jonathan Lovell, Ph.D.
SUNY Empire Innovation Associate Professor, Department of Biomedical Engineering, Jacobs School of Medicine & Biomedical Sciences, University of Buffalo
Jorge C. Blanco, Ph.D.
President and Scientific Director, Sigmovir Biosystems Inc.
Trudy Morrison, Ph.D.
University of Massachusetts Chan Medical School
Vaithilingaraja Arumugaswami, Ph.D.
Adjunct Associate Professor Molecular and Medical Pharmacology, University of California Los Angeles
Pi-Hui Liang, Ph.D.
Janet K. Yamamoto, Ph.D.
Professor and Director of VAB BSL-3 V3-213D Laboratory & LCIV-CA, Dept of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, University of Florida
SIDDAPPA N. BYRAREDDY, Ph.D.
Professor & Vice Chair of Research, Department of Pharmacology & Experimental Neuroscience, The University of Nebraska Medical Center
Tian (Tina) Wang, Ph.D.
Professor, Departments of Microbiology & Immunology and Pathology, Director, NIAID T35 Infectious Diseases & Inflammatory Disorder Training Program, Member, Sealy Institute for Vaccine Sciences
Daniel Kulp, Ph.D.
Associate Professor, Vaccine & Immunotherapy Center, The Wistar Institute
Marcus Buggert, Ph.D.
Assistant Professor, Karolinska Institutet
Martha A. Alexander-Miller, Ph.D.
Dolores G. Evans Ph.D. Chair in Microbiology and Immunology, Professor and Chair, Dept. of Microbiology and Immunology, Director Center for Vaccines at the Extremes of Aging, Wake Forest School of Medicine
Sukrit Srivastava, Ph.D.
Center for Structural Systems Biology (CSSB) & Indian Foundation for Fundamental Research Trust
Gongyi Zhang, Ph.D.
Professor, Department of Immunology and Genomic Medicine, National Jewish Health, Founder, NB Life Laboratory, LLC, Colorado, USA
Oretta Finco, Ph.D.
Head of B Cell Center of Excellence (CoE) and Head of IT-Immunology, GSK (Bacterial Vaccines Unit)
Niraj H. Tolia, Ph.D.
Senior Investigator, Chief, Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, Division of Intramural Research, NIAID/NIH
Jörg Hermann Fritz, Ph.D
Director, McGill Research Center on Complex Traits (MRCCT), Associate Professor, McGill University
Jolieke G. van Oosterwijk, PhD, MSc
Chief Scientific Officer, US BIOLOGIC
Mehul S. Suthar, PhD
Associate Professor, Department of Pediatrics-Infectious Disease, Emory University School of Medicine
Cofounder and CEO, MBF Therapeutics
Jerald Sadoff, PhD
Senior Advisor Development, ID&V Therapeutic Area for Janssen R&D US, Johnson & Johnson
Nash Rochman, PhD
Principal Investigator, National Institutes of Health
Ulo Palm, MD, Ph.D., MBA
Chief Medical Office, Vaxxinity
M. Javad Aman, Ph.D.
President and CEO, AbVacc, Inc
Alexander Rumyantsev, MD, Ph.D., MBA
Therapeutic Area Head, Infectious Diseases, Vaxxinity
Byron Brook, Ph.D.
Research Fellow, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Harvard Institutes of Medicine
Stephen J. Elledge, Ph.D.
Department of Genetics, Harvard Medical School
Peter Nara, Ph.D.
Co-Founders, Chief Scientific Officer, and President of Business Development for Keystone Bio Inc.
Hangwen Li, Ph.D.
Founder, Chairman, and CEO, Stemirna Therapeutics Co., Ltd.
Eric Andrew Appel, Ph.D.
Associate Professor and Director of Graduate Studies, Stanford University
Kevin O. Saunders, Ph.D.
Director, Laboratory of Protein Expression, Duke Human Vaccine Institute, Associate Director, Duke Human Vaccine Institute, Duke University Medical Center
Yuri L. Lyubchenko, PhD, DSc, Professor
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center